Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
Year : 1995  |  Volume : 16  |  Issue : 2  |  Page : 52-56

The treatment of advanced nonseminomatous germ cell tumors.


Dept. of Hematologyy, Oncology, New York Hospital, ?Cornel Med Centre, York Avenue, New York, USA

Correspondence Address:
RM Gelfand
Dept. of Hematologyy, Oncology, New York Hospital, ?Cornel Med Centre, York Avenue, New York, USA

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

The cure rate of nonseminomatous germ cell tumors has improved dramatically since the advent of platinum based chemotherapy. While the majority of patients are cured with first line treatment, the remaining relapsed or refractory patients represent a difficult to manage sub-group. The timing of autologous stem cell transplant (AuSCT) is a controversial issue. While AuSCT is accepted therapy after failure of salvage regimes, some have used this method of treatment at first relapse and even up front in patients with poor prognoses.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed640    
    Printed38    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal